BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16108953)

  • 1. The effect of risperidone on nursing burden associated with caring for patients with dementia.
    Asghar Ali AA; Espinoza R; Kavirajan H; Read S
    J Am Geriatr Soc; 2005 Jul; 53(7):1261-2; author reply 1262-3. PubMed ID: 16108953
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of risperidone on nursing burden associated with caring for patients with dementia.
    Frank L; Kleinman L; Ciesla G; Rupnow MF; Brodaty H
    J Am Geriatr Soc; 2004 Sep; 52(9):1449-55. PubMed ID: 15341545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of risperidone treatment for BPSD.
    Snowdon J; Brodaty H; Ames D; Day S
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease.
    Workman RH; Orengo CA; Bakey AA; Molinari VA; Kunik ME
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):594-7. PubMed ID: 9447503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone in the management of agitation in HIV dementia.
    Lodge P; Tanner M; McKeogh MM
    Palliat Med; 1998 May; 12(3):206-7. PubMed ID: 9743841
    [No Abstract]   [Full Text] [Related]  

  • 7. Licensed indication for risperidone in dementia.
    Phizackerley D
    BMJ; 2014 Dec; 349():g7337. PubMed ID: 25498536
    [No Abstract]   [Full Text] [Related]  

  • 8. Don't use antipsychotics routinely to treat agitation and aggression in people with dementia.
    Corbett A; Burns A; Ballard C
    BMJ; 2014 Nov; 349():g6420. PubMed ID: 25368388
    [No Abstract]   [Full Text] [Related]  

  • 9. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
    Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
    Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
    Bogaisky M
    Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109421
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of disturbed behavior in patients with dementia].
    van de Boogerd ME; Pisters-van Roy AA; Wiertz YD
    Ned Tijdschr Geneeskd; 1992 Jul; 136(29):1419-20. PubMed ID: 1353612
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of agitation in dementia patients].
    González Salvador MT; Arango López C; Lyketsos CG
    Med Clin (Barc); 1999 Nov; 113(15):592-7. PubMed ID: 10605687
    [No Abstract]   [Full Text] [Related]  

  • 14. Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.
    Zaraa AS
    Geriatrics; 2003 Oct; 58(10):48-50, 52-3. PubMed ID: 14569642
    [No Abstract]   [Full Text] [Related]  

  • 15. An unsubstantiated conclusion.
    Reifler BV; Blazer D
    Am J Geriatr Psychiatry; 2015 Feb; 23(2):220. PubMed ID: 25575935
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to Bogaiksy's letter to the editor.
    Freund-Levi Y; Jedenius E; Wahlund LO; Eriksdotter M; Tysen-Bäckström AC; Lärksäter M
    Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109420
    [No Abstract]   [Full Text] [Related]  

  • 17. Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
    Yoshimura R; Shinkai K; Ueda N; Nakamura J
    Pharmacopsychiatry; 2007 Jan; 40(1):9-13. PubMed ID: 17327954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone for Psychosis-Induced Aggression or Agitation.
    Scruth E
    Issues Ment Health Nurs; 2019 Nov; 40(11):988-989. PubMed ID: 31381459
    [No Abstract]   [Full Text] [Related]  

  • 19. [Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!].
    Förstl H
    Dtsch Med Wochenschr; 2013 Jan; 138(1-2):16. PubMed ID: 23250689
    [No Abstract]   [Full Text] [Related]  

  • 20. Clozapine for treatment-resistant agitation in dementia.
    Lee HB; Hanner JA; Yokley JL; Appleby B; Hurowitz L; Lyketsos CG
    J Geriatr Psychiatry Neurol; 2007 Sep; 20(3):178-82. PubMed ID: 17712102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.